SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-002624
Filing Date
2023-02-07
Accepted
2023-02-07 09:03:40
Documents
31
Period of Report
2023-02-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sabs20230206_8k.htm   iXBRL 8-K 31975
2 EXHIBIT 99.1 ex_471788.htm EX-99.1 10731
7 a01.jpg GRAPHIC 76550
8 a02.jpg GRAPHIC 76818
9 a03.jpg GRAPHIC 63779
10 a04.jpg GRAPHIC 59364
11 a05.jpg GRAPHIC 65673
12 a06.jpg GRAPHIC 51171
13 a07.jpg GRAPHIC 48623
14 a08.jpg GRAPHIC 60950
15 a09.jpg GRAPHIC 65909
16 a10.jpg GRAPHIC 52189
17 a11.jpg GRAPHIC 56240
18 a12.jpg GRAPHIC 48195
19 a13.jpg GRAPHIC 61610
20 a14.jpg GRAPHIC 63666
21 a15.jpg GRAPHIC 75058
22 a16.jpg GRAPHIC 53728
23 a17.jpg GRAPHIC 76969
  Complete submission text file 0001437749-23-002624.txt   1653958

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sabs-20230206.xsd EX-101.SCH 4176
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sabs-20230206_def.xml EX-101.DEF 14102
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sabs-20230206_lab.xml EX-101.LAB 18627
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sabs-20230206_pre.xml EX-101.PRE 14124
25 EXTRACTED XBRL INSTANCE DOCUMENT sabs20230206_8k_htm.xml XML 4820
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 23592973
SIC: 2836 Biological Products, (No Diagnostic Substances)